In summary, a typical osteoid osteoma in the coccyx in a 13-year-old boy has been presented-a unique location. The clinical, radiological, and pathological aspects of osteoma are summarized. The relationship of osteoid osteoma to osteoblastoma is stressed; it is also stressed that the occurrence of osteoid osteoma in the coccyx is most unusual.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF00538452 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Osteoid Osteoma in an Elderly Patient: Diagnostic Challenges.
Int J Surg Pathol
January 2025
Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Osteoid osteoma is a benign bone tumor commonly affecting young individuals, with a rare occurrence in older adults. It typically presents with night pain relieved by nonsteroidal anti-inflammatory drugs and is characterized radiographically by a small, radiolucent nidus surrounded by reactive sclerosis. We present a 70-year-old female patient with persistent right hip pain, initially diagnosed as arthritis, who underwent total hip arthroplasty.
View Article and Find Full Text PDFRare encounter: Osteoid osteoma of the coracoid process base - A case report and in-depth literature review.
Int J Surg Case Rep
January 2025
Bone and Joint Diseases Research Center, Department of Orthopedic Surgery, Shiraz University of Medical Sciences, Iran; Golestan Rhematology Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Electronic address:
Introduction And Importance: Osteoid osteoma (OO) is a common benign bone tumor, mostly affecting young adults. Since it often develops in long bones, OO is rarely considered as a cause of chronic shoulder pain.
Case Presentation: We treated an 8-year-old boy with ongoing shoulder pain that was worse at night but improved with NSAIDs.
Impact of reactive sclerosis on outcome of MR-HIFU for osteoid osteomas.
Eur J Radiol
December 2024
Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, D-81377 Munich, Germany.
Objectives: To evaluate the influence of clinical and procedural factors, particularly the thickness of reactive sclerosis, on clinical outcome of MR-guided high-intensity focused ultrasound (MR-HIFU) for the treatment of symptomatic osteoid osteomas (OO) of the extremities.
Materials And Methods: 18 consecutive patients (median age 19.5y) with symptomatic OO of the extremities eligible for MR-HIFU were enrolled in this ongoing prospective study (German Clinical Trials Register; nr.
Osteoid osteoma of the distal phalanx of the finger: Case report and review of literature.
Radiol Case Rep
February 2025
Loyola University Medical Center and Loyola University Chicago, 2160 S First Ave, Maywood, IL 60153, USA.
Osteoid osteoma (OO), a benign bone-forming tumor estimated to account for 3% of all primary bone tumors, rarely occurs in the finger. This case report presents an unusual instance of osteoid osteoma in the finger of a 15-year-old male patient. The lesion was discovered following an initial patient visit for left middle finger pain and swelling for one year without any identifiable injuries.
View Article and Find Full Text PDFOsteoid osteoma and osteoblastoma of the cervical spine in the pediatric population: analysis of the literature and experience with four operated cases.
Childs Nerv Syst
December 2024
Departement of Pediatric Neurosurgery, Hôpital Femme Mère Enfant, Lyon, France.
Background And Aim: Osteoid osteoma (Oo) and osteoblastoma (Ob) are rare primary bone tumors with a higher prevalence in the second decade of life. Treatment can be conservative, but in cases of spinal location, resective surgery is of great importance but may be challenging.
Material And Methods: We report four pediatric cases of Oo and Ob managed in our unit, with different locations at the level of the cervical spine.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!